CORONA — Corona Remedies Balance Sheet
0.000.00%
Last trade - 00:00- IN₹103.03bn
- IN₹104.23bn
- IN₹14.03bn
Annual balance sheet for Corona Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 815 | 690 | 680 | 444 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 874 | 1,003 | 1,212 | 1,458 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 2,915 | 2,899 | 3,389 | 3,483 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 2,488 | 3,116 | 3,847 | 4,343 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 5,950 | 8,306 | 9,299 | 12,051 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1,374 | 2,242 | 2,396 | 3,612 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1,865 | 3,502 | 3,235 | 4,583 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 4,085 | 4,804 | 6,063 | 7,469 |
| Total Liabilities & Shareholders' Equity | 5,950 | 8,306 | 9,299 | 12,051 |
| Total Common Shares Outstanding |